Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation.
D000553:Ambulatory Care / Q000191:economics; D000925:Anticoagulants / Q000008:administration & dosage / Q000191:economics*; D003365:Costs and Cost Analysis; D006493:Heparin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000191:economics*; D017721:Hospital Costs; D006801:Humans; D013514:Surgical Procedures, Operative
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin